Concepedia

Author

Sandra Ulrich

Goethe University Frankfurt

Also Known As

Sandra Ulrich

24

Publications

601

Citations

11

H-Index

22

Concepts

All Affiliations

Goethe University FrankfurtUniversity of Bremen
SU

About

Sandra Ulrich is an author at Goethe University Frankfurt specializing in medicine, pharmacology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

168

2

Biochemistry

2

2

57

3

Cell Biology

2

2

111

4

Natural Sciences

1

1

27

5

Chemical Biology

1

1

27

Sandra Ulrich

×

8

Publications

336

Citations

8

H-Index

YearCitations

Peroxisome Proliferator–Activated Receptor γ as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism

Sandra Ulrich, Stefan Loitsch, Oliver Rau,

Cancer Research

2006

97

Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death

Bettina M. Kaminski, Andreas Weigert, Bernhard Brüne,

Cancer Chemotherapy and Pharmacology

2010

56

PPARγ is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2

Markus S. Schwab, Veerle Reynders, Sandra Ulrich,

APOPTOSIS

2006

55

Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data

Nadine Wentzell, Tania Schink, Ulrike Haug,

Pharmacoepidemiology and Drug Safety

2018

33

De novo ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity

Sandra Ulrich, Andrea Huwiler, Stefan Loitsch,

Biochemical Pharmacology

2007

30

Molecular characterization of EP6—A novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor

Joanna Wiśniewska, Carmen B. Rödl, Astrid S. Kahnt,

Biochemical Pharmacology

2011

27

Competing time-to-event endpoints in cardiology trials: A simulation study to illustrate the importance of an adequate statistical analysis

Geraldine Rauch, Meinhard Kieser, Sandra Ulrich,

European Journal of Preventive Cardiology

2012

22

Isothiocyanate sulforaphane inhibits protooncogenic ornithine decarboxylase activity in colorectal cancer cells<i>via</i>induction of the TGF‐β/Smad signaling pathway

Bettina M. Kaminski, Stefan Loitsch, Meike J. Ochs,

Molecular Nutrition & Food Research

2010

16

Page 1